Notice of Termination and Rescheduling
The American Association for Cancer Research (AACR) and the
American Society of Clinical Oncology (ASCO), after careful consideration and comprehensive
evaluation of currently available information related to the novel coronavirus
(COVID-19) outbreak, have made the difficult decision to terminate the
AACR/ASCO Methods in Clinical Cancer Research Workshop, originally scheduled
for July 25-31, 2020, in Vail, Colorado.
We recognize that this unique program which offers a mix of
education, training, and mentorship is highly valued by the cancer research
community. Although the 2020 Workshop will not take place, we will be extending
the eligibility by one (1) year in order to allow anyone who was eligible for
the 2020 Workshop to apply again for the 2021 Workshop.
AACR and ASCO appreciate your patience and understanding
during this unfortunate situation. If you have any questions, please email firstname.lastname@example.org.
Our heartfelt sympathies go out to everyone impacted by this
global health crisis.
AACR/ASCO Methods in Clinical Cancer Research Workshop
An intensive workshop in the essentials of effective clinical trial designs of therapeutic interventions in the treatment of cancer for clinical fellow and junior faculty clinical researchers in all oncology subspecialties, including radiation and surgical oncology and radiology.
Thomas Braun, PhD
Manuel Hidalgo, MD, PhD
Julie M. Vose, MD
For those protocols using agents from a pharmaceutical company that are not FDA-approved for the disease under study, a letter of commitment from the collaborating company stating that drug will be supplied for the proposed trial or a copy of the correspondence with the company suggesting their likely support of the trial IS STRONGLY ENCOURAGED. Priority will be given to applicants that have a clear letter of support that is uploaded with the application (preferably a letter of commitment, but at minimum, a letter of intent).
Questions?: Please contact Kathryn Leonard, PhD, Scientific Program Administrator, Scientific Programs at email@example.com.
This activity has been approved for AMA PRA Category 1 Credits™.
This workshop is supported by an educational grant from the American Society for Radiation Oncology
Supported by the National Cancer Institute of the National Institutes of Health under Award Number R25CA068647. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.